24
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Prevalence of Autoantibodies to the p53 Protein in Autoimmune Hepatitis

, , , , , & show all
Pages 493-496 | Published online: 07 Jul 2009

  • Alvarez, F., Berg, P.A., Bianchi, F.B., Bianchi, L., Burroughs. A.K., Cancado, E.L., el al. (1999) "International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis", J. Hepatol. 31, 929-938.
  • Meyer zum Büschenfelde, K.H., Lohse, A.W., Manns, M. and Poralla, T. (1990) "Autoimmunity and liver disease". Hepatology 12, 354-363.
  • McFarlane, I.G., Vergani, D. and Eddleston, A.L.W.F. (1998) "Pathogenesis of autoimmune hepatitis". In: Krawitt, E.L., Wiesner, R.H. and Nishioka, M., eds. Autoimmune Liver Diseases (Elsevier Science, Amsterdam), p. 35.
  • Offer, H., Milyavsky, M., Erez, N., Matas, D., Zurer, L., Harris, C.C. and Rotter, V. (2001) "Structural and functional involvement of p53 in BER in vitro and in vivo". Oncoxene 20, 581-589.
  • Ko, L.J. and Prives, C. (1996) "p53: puzzle and paradigm", Genes Deu 10, 1054-1072.
  • Moll, U.M., LaQuaglia, M., Benard, J. and Riou, G. (1995) "Wildtype p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors". Proc. Natl Acad. Sci. USA 92, 4407-4411.
  • Firestein, G.S., Nguyen, K., Aupperle, K.R., Yeo, M., Boyle, D.L. and Zvaifler, N.J. (1996) "Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium". Am. J. Pathol. 149, 2143-2151.
  • Maacke, H., Kessler, A., Schmiegel, W., Roeder, C. Vogel, I., Depert, W. and Kalthoff, H. (1997) "Overexpression of p53 protein during pancreatitis", Br. J. Cancer 75, 1501 -1504.
  • Soussi, T. (2000) "p53 Antibodies in the sera of patients with various types of cancer: a review". Cancer Res. 60, 1777-1788.
  • Raedle, J., Oremek, G., Welker, M., Roth, W.K., Caspary, W.F. and Zeuem, S. (1996) "p53 Autoantibodies in patients with pancreatitis and pancreatic carcinoma", Pancreas 13, 241-246.
  • Fricke, H., Urban, S., Noehl, N. and Folwaczny, C. (1998) "Serum p53 antibodies in patients with chronic inflammatory bowel disease". Gut 42, 899.
  • Kuhn, H.M., Kromminga, A., Flammann, H.T., Frey, M., Layer, P. and Arndt. R. (1999) "p53 Autoantibodies in patients with autoimmune diseases: a quantitative approach". Autoimmunity 31, 229-235.
  • Kovacs, B., Patel, A., Hershey, J.N., Dennis, G.J., Kirschfink, M. and Tsokos, G.C. (1997) "Antibodies against p53 in sera from patients with systemic lupus erythematosus and other rheumatic diseases". Arthritis Rheum. 40, 980-982.
  • Herkel, J., Mimran, A., Erez, N., Kam, N., Lohse, A.W., MarkerHermann, E., Rotter, V. and Cohen, I.R. (2001) "Autoimmunity to the p53 protein is a feature of systemic lupus erythematosus (SLE) related to anti-DNA antibodies". J. Autoimmun. 17, 63-69.
  • Di Cesare, E., Previti, M., Lombardo, F., Di Benedetto, A., Mazzu, N., Romano, G., et al. (2001) "Serum anti-p53 autoantibodies in patients with type 1 diabetes". Ann. Clin. Lab. Sci. 31, 253-258.
  • Lubin, R., Schlichtholz, B., Bengoufa, D., Zaleman, G., Tredaniel, J., Hirsch, A., et al. (1993) "Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: distribution on primary structure and exposure on protein surface". Cancer Res. 53. 5872-5876.
  • [17) Livni, N., Eid, A., Han, Y. Rivkind, A., Rosenmann, E., Blendis, L.M., Shouval, D. and Galun, E. (1995) "p53 Expression in patients with cirrhosis with and without hepatocellular carcinoma". Cancer 75, 2420-2426.
  • Akyol, G., Dursun, A., Poyraz, A., Uluoglu, O., Ataoglu, O., Edaly, N. and Memis, L. (1999) "PS3 and proliferating cell nuclear antigen (PCNA) expression in non-tumoral liver diseases". Pathol. Int. 49, 214-221.
  • Shohat-Foord, O., Bhattacharya, P., Reich, Z. and Rotter, V. (1991) "A DNA binding domain is contained in the C-terminus of wild type p53 protein". Nucl. Acids Res. 19, 5191-5198.
  • Herkel, J., Erez-Alon, N., Mimran, A., Wolkowicz, R., Harmelin, A., Ruiz, P., et al. (2000) "Systemic lupus erythematosus in mice, spontaneous and induced, is associated with autoimmunity to the C-terminal domain of p53 that recognizes damaged DNA". Eur J. Immunol. 30, 977-984.
  • Kanzler, S., Lohr, H., Gerken, G., Galle, P.R. and Lohse, A.W. (2001) "Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience". Z. Castroenterol. 39, 339-341, 344-338.
  • Park, S.Z., Nagomey, D.M. and Czaja, A.J. (2000) "Hepatocellular carcinoma in autoimmune hepatitis". Dig. Dis. Sci. 45, 1944-1948.
  • Arbuthnot, P. Capovilla, A. and Kew, M. (2000) "Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways". J. Castroenterol. Hepatol. 15, 357-368.
  • Graham, A.M., Dollinger, M.M., Howie, S.E. and Harrison, D.J. (1998) "Bile duct cells in primary biliary cirrhosis are 'primed' for apoptosis". Eur. J. Gastiventerol. Hepatol. 10, 553-557.
  • Erez-Alon, N., Herkel, J., Wolkowicz, R., Ruix, P.J., Waisman, A., Rotter, V. and Cohen, I.R. (1998) "Immunity to p53 induced by an idiotypic network of anti-p53 antibodies: generation of sequencespecific anti-DNA antibodies and protection from tumor metastasis". Cancer Res. 58. 5447-5452.
  • Tsuchiya, K., Kiyosawa, K., lmai, H., Sodeyama, T. and Furuta, S. (1994) "Detection of anti-double and anti-single stranded DNA antibodies in chronic liver disease: significance of anti-double stranded DNA antibody in autoimmune hepatitis". J. Gastroenterol. 29, 152-158.
  • Chou, M.J., Lee, S.L., Chen, T.Y. and Tsay, G.J. (1995) "Specificity of antinuclear antibodies in primary biliary cirrhosis". Ann. Rheum. Dis. 54, 148-151.
  • Czaja, A.J., Morshed, S.A., Parveen, S. and Nishioka, M. (1997) "Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis", Hepatology 26, 567-572.
  • Peakman, M., Bevis, L., Mieli-Vergani, G., Mowat, A.P and Vergani, D. (1989) "Double stranded DNA binding in autoimmune chronic active hepatitis and primary sclerosing cholangitis starting in childhood". Autoimmunity 3, 271-280.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.